Oruka Therapeutics (ORKA) Balance Sheet: Assets & Liabilities

Oruka Therapeutics (ORKA) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Oruka Therapeutics reported total assets of $488.62M and total liabilities of $16.69M. Shareholders' equity was $471.93M, up 23.5% from $382.22M a year earlier. Total debt stood at $1.93M against $337.04M in cash and short-term investments, a net cash position of $335.11M. That puts debt-to-equity at 0.00, compared with 0.00 a year earlier.

Oruka Therapeutics Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Oruka Therapeutics, Inc. (ORKA) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017
Current Assets
Cash and Cash Equivalents	46.94	61.58	37.43	42.45	53.36	49.07	8.36	6.61	8.70
Short-Term Investments	290.11	314.07	-	0.00	0.00	0.00	0.00	0.00	3.05
Cash & Short-Term Investments	337.04	375.65	37.43	42.45	53.36	49.07	8.36	6.61	11.75
Accounts Receivable	0.00	0.00	-	0.00	0.00	0.00	0.00	0.00	0.00
Inventory	0.00	0.00	-	0.00	0.00	0.00	0.00	0.00	0.00
Other Current Assets	6.81	1.22	0.16	0.25	1.06	0.90	0.12	0.17	0.55
Total Current Assets	343.86	376.87	37.59	42.70	54.42	49.97	8.48	6.78	12.30
Non-Current Assets
Property, Plant & Equipment (Net)	2.12	1.04	0.26	0.37	0.49	0.45	0.03	0.02	0.04
Long-Term Investments	142.54	18.07	-	0.00	0.00	0.00	0.00	0.00	0.00
Other Non-Current Assets	0.10	0.04	0.01	0.02	0.02	0.01	0.02	0.02	0.02
Total Non-Current Assets	144.76	19.15	-	0.39	0.50	0.46	0.06	0.05	0.07
Total Assets	488.62	396.02	37.86	43.09	54.92	50.43	8.54	6.83	12.37
Current Liabilities
Accounts Payable	4.16	3.46	0.36	0.33	1.12	1.77	0.42	0.23	0.62
Short-Term Debt	0.62	0.21	-	0.10	0.10	0.04	0.03	0.00	0.00
Accrued Liabilities	10.59	3.35	0.28	0.17	2.38	-	-	-	-
Other Current Liabilities	0.01	6.02	-	0.70	2.28	1.69	0.48	0.56	1.45
Total Current Liabilities	15.37	13.04	0.64	1.13	3.50	3.50	0.93	0.79	2.07
Non-Current Liabilities
Long-Term Debt	1.31	0.76	-	0.28	0.38	0.41	0.00	0.00	0.00
Other Non-Current Liabilities	0.00	0.00	-	0.00	0.00	0.00	0.00	0.00	0.02
Total Non-Current Liabilities	1.31	0.76	0.20	0.28	0.38	0.41	0.00	0.00	0.02
Total Liabilities	16.69	13.80	0.84	1.41	3.88	3.91	0.93	0.79	2.09
Stockholders' Equity
Common Stock	0.05	0.04	0.01	0.01	0.01	0.01	0.00	0.01	0.01
Retained Earnings	-189.16	-83.72	-188.74	-183.40	-173.48	-154.15	-144.42	-138.93	-131.00
Accumulated Other Comprehensive Income	0.55	-0.04	-	0.00	0.00	0.00	0.00	0.00	0.00
Additional Paid-in Capital	657.56	463.02	-	225.06	224.51	200.67	152.02	144.95	141.27
Shares Outstanding	48.72	37.44	-	-	-	-	-	-	-
Total Stockholders' Equity	471.93	382.22	37.02	41.67	51.04	46.52	7.61	6.03	10.28
Total Liabilities & Equity	488.62	396.02	-	43.09	54.92	50.43	8.54	6.83	12.37

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Oruka Therapeutics Balance Sheet

How much debt does Oruka Therapeutics have?

Oruka Therapeutics had total debt of $1.93M as of Dec 31, 2025, against $337.04M in cash and short-term investments. Its debt-to-equity ratio was 0.00. Total debt was $968.00K a year earlier.

What are Oruka Therapeutics's total assets?

Oruka Therapeutics reported total assets of $488.62M as of Dec 31, 2025, up 23.4% from $396.02M a year earlier. Total liabilities were $16.69M.

What is Oruka Therapeutics's shareholders' equity?

Oruka Therapeutics's shareholders' equity was $471.93M as of Dec 31, 2025, or about $9.69 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition